ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,176Medicare Part D Prescriptions Filled, Including Refills

Rank: 534 out of 1383

$325K Total Retail Price of All Prescriptions

Rank: 628 out of 1383

356 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
21% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Tennessee
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 356 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

17% of this provider’s 356 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

2% of this provider’s 6,433 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$45 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Tennessee
LEVOTHYROXINE SODIUM 420 383 1 4
LISINOPRIL 227 218 2 3
OMEPRAZOLE 195 191 3 5
HYDROCODONE-ACETAMINOPHEN 192 169 S3 4 1
SIMVASTATIN 182 173 5 2
ATORVASTATIN CALCIUM 180 160 6 18
FUROSEMIDE 174 169 7 7
AMLODIPINE BESYLATE 161 155 8 6
METOPROLOL TARTRATE 138 131 9 9
METOPROLOL SUCCINATE 116 86 10 29
LISINOPRIL-HYDROCHLOROTHIAZIDE 109 107 11 27
SPIRONOLACTONE 108 95 12 67
MELOXICAM 107 105 13 20
TRIAMTERENE-HCTZ 105 95 14 48
POTASSIUM CHLORIDE 102 102 15 12
METFORMIN HCL 99 91 16 8
HYDROCHLOROTHIAZIDE 97 92 17 10
GLIMEPIRIDE 91 77 18 31
ATENOLOL 89 89 19 16
PRAVASTATIN SODIUM 89 77 19 14
METFORMIN HCL ER 89 72 19 47
PANTOPRAZOLE SODIUM 87 77 22 32
GABAPENTIN 77 74 23 11
TRAMADOL HCL 76 72 24 25
ALENDRONATE SODIUM 76 69 24 37
SERTRALINE HCL 75 68 26 21
ESCITALOPRAM OXALATE 74 74 27 99
TRAZODONE HCL 72 60 28 36
LOSARTAN POTASSIUM 72 62 28 23
LOVASTATIN 70 62 30 22
RANITIDINE HCL 63 48 31 19
CARVEDILOL 63 61 31 24
CRESTOR 58 48 33 34
TAMSULOSIN HCL 58 47 33 30
ZETIA 52 50 35 101
CITALOPRAM HBR 50 47 36 15
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 9, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.